For example, the molecular target of hsa-miR-676-3p, SMURF2, is involved in neurodifferentiation in recovery phase following ischemic stroke [23], while its other targets, PTPRB [24] and ANP32B [25], have also been previously investigated in experimental stroke models. Here, PTPRB is linked to stroke disorder.